Top 50 Life Science Angel Investors in United States in October 2023
Top 50 Life Science Angel Investors in United States in October 2023
| Investor | Life Science United States investments |
|---|---|
| Milad Alucozai | 4 |
| bumpkins profile | 4 |
| Sahin Boydas | 4 |
| Darian Shirazi | 3 |
| Esther Dyson | 3 |
| Chris Gibson | 3 |
| Erik Peterson | 3 |
| Kevin Moore | 3 |
| Sujay Jaswa | 2 |
| James Hong | 2 |
| Patrick Collison | 2 |
| Kevin Mahaffey | 2 |
| Brian S. Cohen | 2 |
| Nat Turner | 2 |
| Joshua Elkington | 2 |
| CJ Reim | 2 |
| Michael Chambers | 2 |
| Craig Mundie | 2 |
| Elad Gil | 2 |
| Kathryn Haun | 2 |
| Jay Zaveri | 2 |
| Patrick Yang | 2 |
| Zach Weinberg | 2 |
| David R. Walt | 2 |
| Peter Harris | 2 |
| Jeff Raikes | 1 |
| Vinny Lingham | 1 |
| Daniel Goldman | 1 |
| Jude Gomila | 1 |
| Willard Umphrey | 1 |
| Timothy A. Springer | 1 |
| Elliott Sigal | 1 |
| Zen Chu | 1 |
| Dylan Taylor | 1 |
| Joe Beverly | 1 |
| Jim Greer | 1 |
| Nimi Katragadda | 1 |
| Leonardo DiCaprio | 1 |
| Lu Yoh-Chie | 1 |
| Alice Zhang | 1 |
| Julia Popowitz | 1 |
| Jonathan Milner | 1 |
| Evan Cheng | 1 |
| Nitesh Banta | 1 |
| Paul Manning | 1 |
| Avichal Garg | 1 |
| Scott Garber | 1 |
| Edward Kliphuis | 1 |
| Norman Sorensen | 1 |
| Ali Shaaban | 1 |
Get 300+ niche investors in 2 minutes.
Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.
Find investors — It's Free!Trusted by 21,000+ founders from:
Dr. Milad Alucozai is an Afghan-American neuroscientist, entrepreneur, biotech executive, and global investor with nearly two decades of experience in deep tech, primarily in life sciences. He pushes the boundaries of bioengineering and computational advancements, integrating machine learning and artificial intelligence into biology and medicine.With a strong commitment to commercializing transformative technologies and fostering startup ecosystems worldwide, he is a thought leader and formal mentor for entrepreneurs through organizations like Creative Destruction Lab and the Wyss Institute at Harvard Medical School.Currently, Milad is the head of Bio and Deep Tech at BoxOne Ventures, where he spearheads the firm’s investments in early-stage companies with breakthrough scientific ideas. With nearly 80 early-stage investments, they are recognized as one of North America’s most active venture firms. He is also a Venture Partner at Entrepreneur First, a global fund that has built over 500 companies from scratch with an enterprise value of $10bn. He supports founders with strategy, scaling, business development, securing growth capital, and leadership training, often being their first investor and guiding them from startup inception to IPOs or acquisitions.He started his career in translational neuroscience and multiphysics laboratories before transitioning into founding roles at biotech startups. He is part of the founding team at Mekonos, a San Francisco-based company creating a proprietary cell-engineering platform to support the future of cell and gene therapies. He was also part of the founding team at Corstem, which specialized in machine learning and artificial intelligence software and was later acquired by Circle Cardiovascular, a platform in over 1000 hospitals and more than 40 countries. At Accenture, Milad directed teams of data scientists, designers, and engineers in developing artificial intelligence platforms for global pharmaceutical companies and hospital networks.Milad serves as a Fellow in Healthcare Engineering at the Regenstrief Center. In 2020, he served as an External Advisor to AstraZeneca. He was recognized as a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program. As a George J. Mitchell Scholar, he completed his master’s in Immunology and earned his doctorate from the Richard M. Fairbanks School of Public Health.
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Seed, Series A, Pre-Seed
- United States, Canada, United Kingdom
Portfolio highlights
- Arpeggio Bio — Arpeggio Biosciences leverages state of the art sequencing approaches coupled with powerful machine learning to uncover novel insights into a compound's biological mechanism of action.The company is diverse set of molecular biologists, computer scientists, and biotechnology enthusiasts passionate about understanding where, why, and howtherapeutics work.
- Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
- Eigen Therapeutics — Eigen Therapeutics is a biotechnology company developing combination therapeutics for cancer. The company is in the research and development of synergistic therapies that improve efficacy while reducing the toxicity of small molecule therapies and immunotherapies, enabling physicians to get access to novel drugs in areas of unmet medical needs.
blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.
Show more...Investment focus
- Health Care, Biotechnology, Software
- Seed, Series A, Pre-Seed
- United States, Canada, India
Portfolio highlights
- Sorare — Global Fantasy Football. Collect limited edition digital collectibles, Manage your team and earn prizes!
- Hoth Intelligence — Hoth Intelligence home page. Space age surgical technology brought down to earth.
- Floating Point Group — Floating Point Group is a trading platform provider offering innovative, industry-leading trade execution and settlement
Sahin Boydas is the Head of RemoteTeam at Gusto.
Show more...Investment focus
- Software, Financial Services, FinTech
- Series A, Seed, Series B
- United States, Mexico, Spain
Portfolio highlights
- Postman — Postman is a complete API development environment, used by nearly six million developers and more than 200,000 companies worldwide. It offers a platform for developers or enterprises to build, test, and debug their APIs. The platform intends to use the funds to continue to expand operations and its business reach.Postman is an elegant, flexibletool used to build connected software via APIs quickly, easily, and accurately. It enables API-first development, automated testing, and developer onboarding. The platform's features simplify each step of building an API and streamline collaboration so they can create better APIs faster. Postman was founded in 2014 and is headquartered in San Francisco and has an office in Bangalore, where it was founded. Postman is privately held, with funding from Nexus Venture Partners.
- Owner — Save Money By Converting Third Party Orders To Order Through Your Website. Build Your Customer Database. Increase Sales With Automatic Text and Email Marketing. Setup For You. Built In Loyalty.
- Shield AI — AI pilots will revolutionize battlefields and commercial aviation at a scale greater than the self-driving movement reshaping our highways.
Darian Shirazi is the General Partner of Gradient Ventures.
Show more...Investment focus
- Software, Information Technology, SaaS
- Seed, Series A, Series B
- United States, Germany, Canada
Portfolio highlights
- Resend — Build, test, and send transactional emails at scale.
- Infisical — Infisical is an open-source, end-to-end encrypted tool that supports developers in managing their teams, devices, and infrastructure's secrets and environment variables. Using an end-to-end encrypted method, it avoids the leakage of confidential information to version control and over insecure channels like email.
- Alongside — Alongside builds indexes for cryptocurrencies.
Esther Dyson - Founder @ Way to Wellville
Show more...Investment focus
- Health Care, Medical, Software
- Seed, Series A, Funding Round
- United States, Canada, Russian Federation
Portfolio highlights
- Boxhub — Buy new & used shipping containers with Boxhub. We make buying a shipping container easy & deliver it right to your door. Buy a storage container today!
- Way — Way is a mindful eating app that replaces restrictive diets.
- Humanity — Slow down, or even, reverse your aging.
Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.
Show more...Investment focus
- Biotechnology, Pharmaceutical, Health Care
- Series A, Seed
- United States, France, United Kingdom
Portfolio highlights
- Noetik — Noetik is an AI-native biotechnology company. Our mission is to leverage advanced machine learning methods to discover and develop cancer immunotherapies.
- Amenities — Amenities is the healthcare industry's leading Digital Front Door and patient loyalty platform. We help healthcare providers to acquire new patients and upgrade them to members. Our all-in-one patient app works with most modern EMRs to: 1) register new users into a full EMR account in <30 seconds with full identity verification and noduplicates, 2) help those patients find care options and book appointments with simple, conversion-optimized workflows, 3) seamlessly integrates key patient portal and 3rd party functions (i.e., video visits, secure messaging, test results, and billing), and 4) upgrade patients to members with custom experiences and services offerings (i.e., for Medicare Advantage, concierge memberships, direct-to-employer, or direct primary care patients)
- 64x Bio — 64x Bio builds a platform that increases the speed and scale of mammalian cell line discovery.The company uses a throughput discovery and screening platform and an integrated computational design loop, they develop new ways of generating highly optimized and otherwise unattainable cell lines for the manufacturing of viral vectors, with a specificfocus on those used for cell and gene therapies.
Erik Peterson is the Founder at DormTrader.
Show more...Investment focus
- Software, Biotechnology, SaaS
- Seed, Equity Crowdfunding, Series A
- United States, Canada, Algeria
Portfolio highlights
- Hideout — Hideout makes high-quality food that is available for delivery. Danielle Sobel established the company in Los Angeles, California.
- Abalone Bio — Our Functional Antibody Selection Technology platform (FAST) taps into the potential of the body's biological activities, expanding the reach of antibody drugs.
- Altay Therapeutics — Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for chronic inflammatory conditions. It is currently focused on finding curative therapies for fibrosis, NASH, and liver cancer. It develops novel small molecule drugs against transcriptional regulators that are validated drivers of disease. It wasfounded in 2019 and is headquartered in San Francisco, California.
Kevin Moore has 10 years experience as an angel/opportunity investor and operator. Prior to that, he has over 15 years of progressive technology i-banking, corp dev, and CFO experience at startups and $Bn corporates.
Show more...Investment focus
- Software, Health Care, E-Commerce
- Seed, Pre-Seed, Angel
- United States, India, Canada
Portfolio highlights
- Redbird — Redbird is an operating system that empowers data driven teams to easily create custom applications that automate advanced analytics work in minutes, without writing code.
- SilkChart — SilkChart helps growth teams improve campaigns based on what users are doing in product - without relying on expensive data scientists. We do this through a no code analytics tool that combines marketing and product usage data to identify which channels, audiences, and content maximize revenue growth.
- Augmend — AI-augmented knowledge transfer across developers through a platform that captures and shares expertise.
Sujay Jaswa is founder and managing partner at WndrCo, a holding company that invests in and acquires consumer technology businesses. He serves as Chairman of Aura, Twingate, VPN Super, and is a Director of The Infatuation. Board member of Vy Global Growth (Nasdaq: VYGG). Advisor at Seven1 Sports & Entertainment Agency. He is also a lecturerat the Stanford Graduate School of Business. He formerly served as business founder, vice president of business, and CFO of Dropbox from 2010 to 2015. At Dropbox, Sujay created and led the global business and finance organization. He has a Bachelor’s degree in Economics from Princeton University and an MBA from Harvard Business School.
Show more...Investment focus
- Software, Media and Entertainment, Internet
- Seed, Series B, Series A
- United States, Spain, Germany
Portfolio highlights
- HUBUC — A single API-platform that allows any business to embed financial services capabilities into their products. e.g Uber can issue branded credit cards for all Uber drivers and Walmart provides customers a simple way to better manage and control their everyday finances, with no regulatory burden or compliance requirements in a few weeks.
- point.me — Maximize your miles with our real-time search engine. Easily compare reward flights across airlines to find the best deal. So you get better flights, for fewer points.
- Fireside — Fireside is the first interactive streaming platform that invites you to be part of the show. Co-founded by Falon Fatemi and Mark Cuban the media and entertainment networks of the future are emerging on Fireside.
James Hong
Show more...Investment focus
- E-Commerce, Mobile, Internet
- Seed, Series A, Angel
- United States
Portfolio highlights
- Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
- Hatch — At Hatch, we're dreaming up ways to help people sleep better. Our sleep products and services have helped over a million people get a good night's rest. We're on a mission to make sleep easier for everyone with innovative, all-in-one solutions for newborns through adults.
- Alchemy — Whether you're a beginner, working on a side project, or one of the largest teams in the blockchain space, Alchemy makes Ethereum development easy with enhanced APIs, node infrastructure, and developer tooling. Get started for free!
Patrick Collison is a Content Strategist for Stripe.
Show more...Investment focus
- Software, Financial Services, Enterprise Software
- Seed, Series A, Series C
- United States, United Kingdom, India
Portfolio highlights
- Polywork — Launch an AI-powered personal website to showcase your work, grow your personal brand, or start your side hustle.
- Rain Industries — Every wildfire starts small. Rain contains wildfires within 10 minutes of ignition with autonomous drones.
- keen technologies — keen technologies provides SAP education and other skill based education that needs to the students in current market needs.
Kevin Patrick Mahaffey is the Founder of Lookout and SNR. He is also the Executive Chairman of Stork Club and an Investor.
Show more...Investment focus
- Software, SaaS, Enterprise Software
- Seed, Series A, Pre-Seed
- United States, Canada, India
Portfolio highlights
- dcbel — dcbel's mission is to deliver energy that lets people live a life without compromise.dcbel™ (formerly known as Ossiaco) sits at the nexus of residential solar power, electric vehicle charging, the smart home, and customer-centric utilities. The dcbel team has a proven history of rethinking energy distribution for everything from largeutility customers to distributed energy resource providers.dcbel's AI-driven sustainable technologies enable people to leverage solar energy to power their cars, their homes, and their lifestyles.dcbel has numerous worldwide patents in power electronics and power conversion and is backed by a number of globally respected investors.
- HumanFirst — The complete productivity suite to transform natural language into business insights and AI training data
- RecruitBot — RecruitBot Is A Platform That Helps You Find Top Talent Through Machine Learning, AI & Cloud Tools. Contact RecruitBot, The Top Online, AI Recruiting Agency
Considered one of the fathers of science & technology strategic communications - founded Technology Solutions, Inc. in 1983. Client list read like a who's who list of startup technology companies in computing, communication, software, education, and entertainment. Maintained a strategic communications partnership with Sony & IBMCorporation (10 years). Received the Gold CIPRA award in 1998 for the IBM Deep Blue/Gary Kasparov Chess Match. In 1996, TSI was recognized as the #1 fastest growing agency in the United States. Sold the company to The McCann Erickson World Group in 1997 and became the Vice Chairman. Created Focus Technology, an organization that provided qualitative research and instituted the RPM model of integrated strategic communications providing ultra-competitive technology clients the ability to quickly discover and leverage their key strengths as well as mitigate their destructive weaknesses.Brian was a pioneer in the founding of a number of the first computing publications including Computer Systems News and InformationWeek magazine. Now serves as Chairman of the New York Angels. He is very devoted to the New York City startup community.Developed the AIMS (Applied Internet Media Studies) Program, a senior/graduate level college semester program where students will be rigorously trained to use the internet professionally.Frequent speaker on strategic communication, entrepreneurism and early startup investing. Now writing a book for McGraw Hill - a new organizational product launch model.Received the Distinguished Alumnus Award, holds a Masters Degree in Science Communications from Boston University's School of Communications.
Show more...Investment focus
- Software, SaaS, Mobile
- Seed, Series A, Funding Round
- United States, Israel
Portfolio highlights
- Authorea — Authorea is a provider of a collaborative platform that is designed to read, write, discuss, and publish research. Its platform serves as a powerful document editor for researchers and provides collaborative editing, automatic citation formatting, tracking changes and it has the ability to make any document public or fully private that enablesresearchers to write documents together and attach references, figures, data, and source code. It improves how researchers work and make breakthrough discoveries by tackling one of the most important parts of the research cycle which is communication.
- CourseHorse — CourseHorse is a provider of a learning platform used to centralize the learning opportunities. Its platform partners with providers of Spanish lessons, cooking courses, yoga classes, and other classes to create a single destination for people seeking personal interest education that enables people to increase ease and confidence in discovering thepath to personal enrichment.It was founded in 2011 and is headquartered in New York.
- Boundless Mind — Thrive Global's mission is to end the burnout epidemic with sustainable, science-based solutions that unlock employee performance and enhance well-being through our behavior change technology.
Before co-founding Flatiron, Nat was Co-Founder and CEO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Nat started numerousinternet companies and also worked at Say Media and First Round Capital. An active angel investor, Nat has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Nat earned a Bachelor of Science degree cum laude in Economics with concentrations in Entrepreneurship and Marketing from The Wharton School of the University of Pennsylvania. In his spare time, Nat is an avid golfer and tries to trick trout with fake bugs.
Show more...Investment focus
- Health Care, Software, Medical
- Seed, Series A, Series B
- United States, China
Portfolio highlights
- CollX — Snap photos of them and instantly get the current market price. Add them to your collection and track your overall portfolio value.
- Collectors — Helping collectors to pursue their passion.
- Iterative Scopes — Iterative Scopes provides gastroenterologists with machine learning-powered diagnostic tools that help them prevent colon cancer and improve patient outcomes
Joshua Elkington
Show more...Investment focus
- Biopharma, Life Science, Biotechnology
- Seed
- United States
Portfolio highlights
- Tierra Biosciences, Inc. — Speed, scale and simplicity with protein synthesis on-demand. Discover your portal to thousands of custom proteins. Get testable material with a single input.
- Tierra Biosciences, Inc. — Speed, scale and simplicity with protein synthesis on-demand. Discover your portal to thousands of custom proteins. Get testable material with a single input.
CJ Reim is a co-founder of Amity Ventures and an active investor in Avochato, Carta, Ouster, Talkdesk, and more than 15 other growing technology businesses. CJ is currently focused on investments in software, fintech, and consumer sectors, and represents Amity on the boards of Avochato and MaintainX.Prior to Amity, CJ was a Vice President on theinvestment team at Highland Capital Partners, where he focused on technology investments across all stages of company growth. He also led the Summer@Highland entrepreneurship program which, over its nine-year history, has mentored 50 student-led startups from inception. CJ is originally from Minnesota and holds a B.S. in Management with concentrations in Finance and Information Systems from Boston College. Outside of Amity, CJ enjoys CrossFit, freediving, and downhill skiing.
Show more...Investment focus
- Robotics, E-Commerce, Internet
- Series A, Seed, Series B
- United States
Portfolio highlights
- Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
- Burrow — Meet Burrow. We make clever, uncompromising furniture and other nice things fit for modern life at home. From our comfortable, customizable sofas, sectionals, loveseats, and armchairs to our fashionable, functional rugs and tables, and five unique collections of decorative pillows and throw blankets, Burrow is the perfect place to start when shopping for your home.
- Arkive — Arkive is a web3 museum of real world items, curated by a community of passionate hobbyists, collectors, artists, designers, and creators.
Michael Chambers is the Co-Founder at Agathos Biologics.Michael’s vision and leadership of Aldevron has resulted in several milestones including the 2004 acquisition of Genovac Antibody Technology of Freiburg, Germany; the 2009 expansion of protein production in Madison, Wisconsin; private equity transactions by TA Associates in 2017 and EQT in2020; and the purchase of Aldevron by Danaher for $9.6 billion in 2021. Michael is committed to ethical pharmaceutical development and his leadership will enable Agathos to create new paradigms in biotechnology to achieve these goals. Michael received Bachelor of Science degrees in biotechnology, chemistry, and microbiology from North Dakota State University.
Show more...Investment focus
- Biotechnology, Genetics, Life Science
- Series A, Funding Round
- United States
Portfolio highlights
- Kytopen — Kytopen is pioneering a novel and non-viral process to engineer human cells for therapeutic applications in immuno-oncology and genetic disorders.
- Erbi Biosystems — Erbi Biosystems is a transformative microfluidic bioprocess instrumentation company.
- 64x Bio — 64x Bio builds a platform that increases the speed and scale of mammalian cell line discovery.The company uses a throughput discovery and screening platform and an integrated computational design loop, they develop new ways of generating highly optimized and otherwise unattainable cell lines for the manufacturing of viral vectors, with a specificfocus on those used for cell and gene therapies.
Craig Mundie is chief research and strategy officer of Microsoft Corp., reporting to CEO Steve Ballmer. In this role, he oversees Microsoft Research, one of the world’s largest computer-science research organizations, and is responsible for Microsoft’s long-term technology strategy. Mundie also directs a number of technology incubations, and workswith government and business leaders around the world on technology policy, regulation and standards.Mundie has spent much of his career building startups in various fields, including supercomputing, consumer electronics, education, healthcare and robotics. He joined Microsoft in 1992 to create and run the Consumer Platforms Division, which developed non-PC platforms such as the Windows CE operating system; software for the Handheld PC, Pocket PC and Auto PC; and early console-gaming products. Mundie also started Microsoft’s digital-TV efforts, acquiring and managing its WebTV Networks subsidiary, and built its fast-growing healthcare solutions business.Prior to his current role, Mundie served as Microsoft’s chief technical officer for advanced strategies and policy, working with Microsoft Chairman Bill Gates to develop the company’s global strategies around technical, business and policy issues. Another long-standing focus for Mundie is privacy, security and cyber-security. He initiated Microsoft’s Trustworthy Computing initiative, which has leveraged new software-development practices to significantly improve the security of the company’s products.For more than a decade, Mundie has also been Microsoft’s principal technology-policy liaison to the U.S. and foreign governments, with an emphasis on China, India and Russia. He has served on the U.S. National Security Telecommunications Advisory Committee and the Markle Foundation Task Force on National Security in the Information Age. In April 2009 Mundie was appointed by President Barack Obama to the President’s Council of Advisors on Science and Technology.Mundie started his career in 1970, working on operating-system development for the Data General NOVA at Systems Equipment Corp. (SEC) while still studying at Georgia Tech. SEC was subsequently acquired by Data General Corp., where Mundie went on to develop the INFOS data-management system. In 1977 Mundie moved to Data General’s advanced development facility in Research Triangle Park, N.C., ultimately becoming its director. In 1982, Mundie was one of three co-founders of Alliant Computer Systems Corp., which developed vector-parallel mini-supercomputers. He held a variety of positions at Alliant before becoming CEO. The company shut down in 1992.Mundie holds a bachelor’s degree in electrical engineering and a master’s degree in information theory and computer science from Georgia Tech. Mundie enjoys traveling and spending time on his boat. He is married, with one married daughter.
Show more...Investment focus
- Life Science, Chemical, Genetics
- Seed, Series B, Series C
- United States
Portfolio highlights
- Stoicheia — Stoicheia is a nanotechnology company accelerating materials discovery by defining and expanding the materials genome. Using its proprietary lithography technology, Stoicheia has developed a way to create Megalibraries of nanomaterials on a chip. The company's technology also can be used to combine elements in new ways — already creatingstructures comprising up to seven elements.
- Exicure — Exicure is Formerly Known as AuraSense Therapeuticsis. Exicure is developing a new class of immunomodulatory and gene silencing drugs against validated targets. Our 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of nucleic acid therapeutics in multiple organs. Our lead programs address diseases from inflammatorydisorders to oncology.SNA constructs overcome one of the most difficult obstacles to nucleic acid therapeutics: safe and effective delivery into cells and tissues. SNA constructs exhibit unparalleled transfection efficiency into numerous cell and tissue types including the skin without carriers or transfection agents. Moreover, SNAs can be used as potent immunotherapeutic agents for the treatment of cancer or infectious disease.
Elad Gil is the Co-Founder of Color Genomics. He previously worked at Twitter as a Vice President. Elad Gil attended the Massachusetts Institute of Technology.
Show more...Investment focus
- Software, Information Technology, Artificial Intelligence
- Seed, Series A, Series B
- United States, United Kingdom, Israel
Portfolio highlights
- Resend — Build, test, and send transactional emails at scale.
- Socket — Socket fights vulnerabilities and provides visibility, defense-in-depth, and proactive supply chain protection for JavaScript, Python, and Go dependencies.
- Neon — Postgres made for developers. Easy to Use, Scalable, Cost efficient solution for your next project.
Katie Haun is a General Partner at Andreessen Horowitz. She serves on the boards of Coinbase and HackerOne and has invested in and advised tech companies from seed to Series E stage. Katie teaches a management course at Stanford Business School and previously taught cybercrime at Stanford Law School. Previously, she spent a decade as a federalprosecutor with the U.S. Department of Justice focusing on fraud, cyber, and corporate crime alongside agencies including the SEC, FBI, and Treasury. She created the government’s first cryptocurrency task force and led investigations into the Mt. Gox hack and the corrupt agents on the Silk Road task force. She also prosecuted RICO murders, organized crime, public corruption, gangs, and money laundering, and held senior policy positions at headquarters in both the National Security Division and Attorney General’s office where her portfolio included antitrust, tax, and national security. Katie clerked for U.S. Supreme Court Justice Anthony Kennedy and is an honors graduate of Stanford Law School.
Show more...Investment focus
- Blockchain, Financial Services, FinTech
- Funding Round, Seed, Series A
- United States, United Kingdom
Portfolio highlights
- Aptos — Committed to developing products and applications on the Aptos blockchain that redefine the web3 user experience.
- Primer — Primer is the world's first community built for curious and ambitious kids to find and explore their interests together.
- Autograph — Autograph is an NFT platform that brings together the most iconic brands and legendary names in sports, entertainment, and culture to create unique digital collections and experiences. Autograph is building the future of fandom through a streamlined and inclusive process, authentic and creative products, and exclusive partnerships.
Jay Zaveri has been serving Social Capital as a partner since November 2015. He also founded CloudOn and Future Thought Productions.
Show more...Investment focus
- Health Care, Biotechnology, Information Technology
- Seed, Series A, Funding Round
- United States, Japan, Canada
Portfolio highlights
- Cleerly — Cleerly is a healthcare company whose mission is to create digital care pathways to prevent heart attacks. The company develops a new standard for coronary artery disease by integrating quality clinical science with the latest-generation AI, in order to offer actionable clinical insights to every stakeholder in the heart care pathway.Throughthese data-driven solutions, the company aims to provide a comprehensive solution for cardiovascular disease evaluation that offers value to the healthcare system and improves heart health for patients at risk of heart attacks.
- BitClout — BitClout is a platform owned by its users. Bitcoin is decentralizing money, BitClout is decentralizing social media.
- Kingdom Supercultures — Kingdom Supercultures create microbial cultures that help food manufacturers to create new foods with boosted benefits. It re-assembles nature's microbes into new combinations, creating plant-based foods that taste like dairy, low-alcohol beverages with full flavor, and natural preservatives that work as well as artificial ones.They workwith clients across diverse industries including food, beverage, personal care, beauty, and more. Their technology comprises an expansive biobank of GRAS microbial strains, high-resolution strain characterization, and new algorithms for predicting and assembling microbial communities.
Patrick Yang, General Partner at Amity Ventures, has led the firm’s investments in CaptivateIQ, Evisort, Flick, MoQuality, TruePill, and Vowel. He sits on the boards of Evisort and MoQuality. His primary areas of investment focus include AI, consumer, logistics, mobility, and software. Patrick co-founded Amity Ventures with CJ Reim in 2017 afterthe two worked together at Highland Capital Partners.Prior to Amity, Patrick was a Vice President at Highland, where he sourced the firm’s investment in nuTonomy, an autonomous vehicle startup acquired by Delphi one year later for $450M. Patrick is from the Bay Area and holds a B.S. in Business Administration with a concentration in Engineering Leadership from University of California, Berkeley.Pat currently serves on the board of Advancing Women in Product, a non-profit that empowers women to enter and succeed in product management roles. In his free time, he enjoys hiking and eating in the San Francisco area, and attending sporting events—especially Warriors, 49ers, and Giants games.
Show more...Investment focus
- Software, Health Care, E-Commerce
- Series A, Seed, Series B
- United States
Portfolio highlights
- Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
- Burrow — Meet Burrow. We make clever, uncompromising furniture and other nice things fit for modern life at home. From our comfortable, customizable sofas, sectionals, loveseats, and armchairs to our fashionable, functional rugs and tables, and five unique collections of decorative pillows and throw blankets, Burrow is the perfect place to start when shopping for your home.
- Innerwell — Innerwell combines personalized guidance from licensed therapists like you with the expansive power of psychedelics to treat anxiety and depression.
Before co-founding Flatiron, Zach was Co-Founder, President and COO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Zach co-foundedEatNow.com which was privately acquired. An active angel investor, Zach has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough.com, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Zach studied economics and entrepreneurship at The Wharton School at the University of Pennsylvania.
Show more...Investment focus
- Health Care, Software, Medical
- Seed, Series A, Series B
- United States, Israel, Colombia
Portfolio highlights
- Scoop — Thrive in a hybrid work environment with Scoop's solutions for Workplace Safety, Workplace Utilization, Team Coordination, Desk Management, and Commute.
- Iterative Scopes — Iterative Scopes provides gastroenterologists with machine learning-powered diagnostic tools that help them prevent colon cancer and improve patient outcomes
- Overwatch Research — Generate accurate in vivo study data as a part of your efficient, connected R&D.
David is Professor in the Department of Pathology, Brigham and Women’s Hospital and Wyss Institute for Biologically Inspired Engineering, and is a Howard Hughes Medical Institute Professor. David is the Scientific Founder of Illumina Inc. and Quanterix Corp and has co-founded several other life sciences startups. David has published over 300peer-reviewed papers and has over 75 issued US patents. He has received numerous national and international awards and honors for his fundamental and applied work in the field of optical microwell arrays and single molecules including the American Chemical Society Kathryn C. Hach Award for Entrepreneurial Success, Ralph Adams Award in Bioanalytical Chemistry, the American Chemical Society Gustavus John Esselen Award, Analytical Chemistry Spectrochemical Analysis Award, the Pittsburgh Analytical Chemistry Award, and the ACS National Award for Creative Invention. He is a member of the National Academy of Engineering, the National Academy of Medicine, a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Institute for Medical and Biological Engineering, and a Fellow of the National Academy of Inventors. He received a BS in Chemistry from the University of Michigan and a PhD in Chemical Biology from SUNY at Stony Brook, and did postdoctoral studies at MIT.
Show more...Investment focus
- Biotechnology, Genetics, Life Science
- Seed, Series A, Series B
- United States
Portfolio highlights
- Vizgen — The next generation of genomics, expanding the impact of spatial context and demonstrating the potential of in situ single-cell spatial genomics.
- Stoicheia — Stoicheia is a nanotechnology company accelerating materials discovery by defining and expanding the materials genome. Using its proprietary lithography technology, Stoicheia has developed a way to create Megalibraries of nanomaterials on a chip. The company's technology also can be used to combine elements in new ways — already creatingstructures comprising up to seven elements.
- Torus Biosystems — Torus Biosystems offers an apparatus for DNA testing for scientific and medical research purposes in the fields of consumer products, food for human beings or animals, hygienic and beauty care for human beings or animals, agriculture, horticulture, and forestry. The company was founded in 2019 and is headquartered in Cambridge, Massachusetts.
Peter Harris
Show more...Investment focus
- Life Science, Biotechnology, Health Diagnostics
- Seed
- United States
Portfolio highlights
- CND Life Sciences — Our suite of neurodiagnostic tests give clinicians access to objective pathological insights on diseases that are often difficult to diagnose
Jeff Raikes is the Co-founder of the Raikes Foundation.
Show more...Investment focus
- Video, AgTech, Sports
- Series A, Series C, Series D
- United States
Portfolio highlights
- Hudl — Hudl provides video review and performance analysis tools for sports teams and athletes at every level.
- Epicrop Technologies — Revolutionary epigenetic technologies for crop enhancement producing increases in yield, resilience, and stress tolerance.
Vinny Lingham is Co-Founder & CEO at Civic. He was the founder and CEO of Gyft, a mobile gift card app that allows customers to buy, store, send and redeem gift cards conveniently from their mobile device. He is also the founder of Yola.com, a web development and hosting company that enables users without prior programming knowledge to developwebsites. Vinny is the recipient of numerous awards, including Top Young ICT Entrepreneur in Africa (2006) and was also a finalist for Men’s Health Best Man (2009) and ICT Personality of the Year in South Africa (2008). He also previously founded Clicks2Customers, which also won the Top Technology Company award in South Africa in 2006. He has previously served on marketing advisory boards for Nasdaq listed Valueclick and Yahoo, was also selected as an Endeavor “High Impact Entrepreneur” in 2006. Vinny studied a B.Com (Information Systems) at the University of Cape Town.
Show more...Investment focus
- Blockchain, Internet, Cryptocurrency
- Seed, Funding Round, Angel
- United States, South Africa, United Kingdom
Portfolio highlights
- TipLink — TipLink helps send crypto with a link. Someone with crypto can create a account and send that link to anyone over any platform. It’s like buying a gift card, connect the client's crypto wallet of choice and create a account by depositing how much they want to send.
- Afterparty — Your favorite creators are here! Get 1 on 1 unfiltered experiences with creators through Afterparty livestreams or chat 24/7 through AI powered conversations
- Collectibles.com — Collectibles.com is a Web3 community and marketplace for collectors and the worldwide collectibles sector.
Daniel Goldman Managing Partner of Ignition Angels/Keystone CatalystsA pioneer in online gaming and online communities, Daniel has a passion for applying technology to real world problems. He studied cognitive neuroscience at Columbia and became COO and VP PD at Posit Science, with Dr. Michael Merzenich, the world leading expert onneuroplasticity. There he incorporated the latest understanding of reward systems, neuroplasticity and the science of play into products for cognitive rehabilitation. Currently an angel investor, Daniel’s interest is for a world where everyone has ubiquitous access to opportunity, both social and economic, as well as freedom of thought.
Show more...Investment focus
- Video, Sports, Life Science
- Seed, Convertible Note
- United States
Portfolio highlights
- Chai — Chai allows anyone to detect anything, anywhere with DNA, transforming biotech into an everyday productivity tool. Chai's Real-Time PCR and qPCR instruments are as accurate as a lab test, but cost 10x less, and are easy enough for anyone to use. Chai also develops PCR Master Mixes for the detection any pathogen, bacteria, virus, allergen,gene, species, or DNA tracer on-site at the point of need.Chai is impacting large industries such as food, agriculture, research, education, and security, while providing new solutions to combat consumer fraud, protect the environment, improve global health, and make small businesses like microbrewers more profitable.
- Grit Media — Grit is a sports media start-up creating original digital videos for Gen Z.
- Advanced Ionics — Advanced Ionics has created an electrolyzer that allows industrial hydrogen users to produce green hydrogen for less than $1/kg.
Jude Gomila is currently CEO and Founder of the startup Golden.
Show more...Investment focus
- Software, Biotechnology, Information Technology
- Seed, Pre-Seed, Angel
- United States, United Kingdom, Canada
Portfolio highlights
- Parcha AI — Parcha is an AI-powered enterprise software that enables businesses to automate their scale compliance and operations.
- Monitaur — Reduce operational overhead, improve security, optimize performance, and deliver amazing customer experiences with our end-to-end, hybrid observability & APM platform built for decentralized apps and infrastructure.
- Gradia Health — Gradia is an integrated, concierge care platform designed for clinics to support patients with chronic conditions.
Bill is the Chairman and Co-Founder of the Pear Tree Funds, the President of Pear Tree Investment Advisors, Inc., and the Chairman of U.S. Boston Capital Corporation. He has over 40 years of experience in the finance and investment management business.Bill holds the Chartered Financial Analyst (CFA) designation and is a member of the CFAInstitute and the Boston Security Analysts Society. He obtained his JD from Harvard Law School, an LLM in taxation from Boston University School of Law, a Masters in Personnel Administration from George Washington University, and a BS with distinction from the United States Naval Academy in Annapolis, Maryland.
Show more...Investment focus
- Analytics, Life Science, Biotechnology
- Seed
- United States
Portfolio highlights
- Thrive Bioscience — Thrive Bioscience is commercializing a family of instruments and software that provide imaging, analytics, and automation to significantly improve cell culture and the analysis of live cells. Thrive’s instruments empower biologists to deliver consistent, reproducible results by leveraging microscopy, robotics, fluidics, and other fields, to captureimages and data and provide analysis, reports, guidance, documentation, and a database on the cells and on cell culture processes.
Timothy Springer is an internationally recognized leader in structural biology and immunology. With over 500 peer-reviewed publications that have received over 90,000 citations, he is one of the most highly cited scientists in any field. Timothy Springer received his Ph.D. from Harvard University in 1976, and subsequent post-doctoral training withDr. Cesar Milstein in Cambridge, UK. Timothy Springer has been elected to the National Academy of Sciences and to the American Academy of Arts and Sciences. Among numerous awards and honors, Timothy Springer is a recipient of the Royal Society of Medicine Medal, the William B. Coley Medal from the Cancer Research Institute, and the Crafoord Prize from the Swedish Academy of Sciences. Timothy Springer's research laid the foundation for a new class of pharmaceuticals, the selective adhesion molecule inhibitors, which include the approved drugs, alefacept, efalizumab, and natalizumab. Timothy Springer was the Founder of LeukoSite, a biotechnology company acquired by Millennium Pharmaceuticals in 1999. LeukoSite developed therapeutics for inflammatory, autoimmune, and cancer applications, including FDA-approved Campath™.
Show more...Investment focus
- Biotechnology, Medical, Health Care
- Series A, Series B, Seed
- United States, Canada
Portfolio highlights
- Prenuvo — Prenuvo offers MRI scanning systems that help in early detection of cancer and other diseases.
- Seismic Therapeutic — Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using its IMPACT™ platform, the company is addressing the central challenges of biologics discovery and development by fully integrating machine learning with the key elements ofbiologics drug discovery – structural biology, protein engineering, and translational immunology – to create optimized therapies on an accelerated path to patients. Seismic Therapeutic has an emerging pipeline of novel biologics to address adaptive immune system dysregulation to treat autoimmune diseases.
- Tectonic Therapeutic — Tectonic, co-founded by Andrew Kruse and Tim Springer of Harvard Medical School, is transforming the discovery of antibodies and other biologic drugs targeting G-protein Coupled Receptors (GPCRs).
Elliott Sigal, M.D., Ph.D. joined NEA as a Venture Partner and Senior Advisor in 2014. He is a former Executive Vice President and Director of Bristol-Myers Squibb, and served as Chief Scientific Officer and President of R&D for Bristol-Myers Squibb from 2004 until 2013. He was a principal architect of the successful Biopharma TransformationStrategy of the company. He has been instrumental in increasing R&D productivity, developing the company’s strategy in biologics and acquiring external innovation in Bristol’s String of Pearls initiative. Under his leadership, fourteen new medicines have come to market including Abilify (Schizophrenia, Bipolar Disorder), Reyataz (HIV/AIDS), Erbitux (Colon Cancer), Baraclude (Hepatitis B), Orencia (Rheumatoid Arthritis), Sprycel (Leukemia), Atripla (HIV/AIDS), Ixempra (Breast Cancer), Onglyza and Kombiglyze (Diabetes), Nulojix (Transplantation), Eliquis (Anticoagulant), Yervoy (Melanoma), and Forxiga (Diabetes). Among his accomplishments in various therapeutic areas was building BMS research into a lead position in the promising area of immuno-oncology. In 2012, Dr. Sigal was named the best R&D chief in the pharmaceutical industry by Scrip Intelligence.Dr. Sigal currently serves as a senior advisor to the healthcare team of New Enterprise Associates and also consults for select biotechnology companies. Dr. Sigal received his M.D. from the University of Chicago in 1981 and trained in Internal Medicine and Pulmonary Medicine at the University of California, San Francisco (UCSF). Prior to medical school he studied engineering at Purdue University, where he received a B.S., M.S., and Ph.D. Dr. Sigal serves as a member of the Board of Directors for the Mead Johnson Nutrition Company and the Melanoma Research Alliance.
Show more...Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B
- United States
Portfolio highlights
- Surface Oncology — Surface Oncology is developing next generation immunotherapies that target the immune-suppressive tumor microenvironment to attack cancer.
- Mersana Therapeutics — Mersana Therapeutics employs its biodegradable polymer platform to create new and better medicines. They are advancing their own clinical-stage pipeline of novel compounds with the potential to address multiple oncology indications. It was founded in 2005 and headquartered in Cambridge, Massachusetts.
Zen Chu believes that now is the best time in history for healthcare entrepreneurs and engineers to create the data, systems and products to help medicine scale and serve more patients with higher quality at lower cost. He created and teaches the MIT Healthcare Ventures graduate courses within the pioneering Health Science & Technology (HST)program, a joint initiative between MIT, Harvard Medical School and the Boston academic hospitals. As faculty director for the HackingMedicine.MIT.edu health innovation leadership initiatives, Zen mentors physician entrepreneurs, early-stage startups and health corporations adapting to global digital healthcare transformation, changing healthcare incentives, growth in emerging markets, and new disruptive technologies that re-engineer medicine.As Managing Director of Accelerated Medical Ventures, Zen specializes in building early-stage medical technology and healthcare service companies, usually serving as co-founder and first investor. AMV’s portfolio spans Boston, Silicon Valley and China, including PillPack.com, Figure1.com, 3D-Matrix Medical [JASDAQ: 7777], Curoverse Genomics, PathFinder Regenerative Medicine [OTCQB: PFND], BitGym.com, Aptible, DirectDermatology.com and a couple of companies still in stealth mode.Alongside four world-renowned MIT biomaterials professors, Zen co-founded 3D-Matrix Medical Inc., serving as the first CEO for the venture-backed MIT regenerative medicine company whose injectable gel drug delivery products are treating patients and enabling new regenerative medicine research, with a successful IPO in 2011. He has managed and led new ventures for Harvard Medical School, Harvard’s Wyss Institute for Bioengineering, NetVentures and Hewlett-Packard.Zen earned a Masters of Public & Private Management from Yale University and a BS in biomedical/electrical engineering from SMU. He's married to another entrepreneur-turned-venture investor and they are raising three aspiring makers in Brookline, MA.
Show more...Investment focus
- Health Care, Medical, mHealth
- Series A, Seed
- United States, Canada
Portfolio highlights
- Filtricine — Transforming Cancer Management
- Abridge — For patients, clinicians, and enterprise, our audio-based solutions capture the details and summarize medical conversations, anywhere care happens.
- Lora DiCarlo Inc. — Lora DiCarlo used biomimicry to translate human mouth, tongue, and finger-like haptics into microrobotic mechanisms that feel like a human partner. Osé adjusts to each woman's unique physiology for a personal fit that makes achieving the elusive blended orgasm easy.
Dylan Taylor is a global business leader, commercial astronaut, thought leader and philanthropist. Currently, Dylan serves as Chairman & CEO of Voyager Space, a multi-national space exploration firm focused on building the next generation of space infrastructure for NASA and other global space agencies.Dylan has been recognized by HarvardUniversity, SpaceNews, the BBC, the Financial Times, Pitchbook, CNBC, CNN and others as having played a seminal role in the growth of the private space industry. As an early-stage investor in more than 50 emerging space ventures, including Axiom, Kepler, York, Astrobotic, LeoLabs, Relativity, and Planet, Dylan is widely considered the most active private space investor in the world.Dylan’s technical background, global business experience and unbridled passion for space make him a unique figure within his industry. As a thought leader and futurist, he has written many popular pieces on the future of the space industry for Forbes, FastCompany, Newsweek, SpaceNews, The Space Review, and Space.com. As a speaker, Dylan has keynoted many of the major space conferences around the world and has appeared regularly on Bloomberg, Fox Business, and CNBC.Dylan has extensive global business experience as both a board director and CEO in several industries, including advanced electronics, finance and real estate. He previously served as a Director for UMB Bank, a Fortune 500 company based in Kansas City and as a mutual fund director for the Jackson Funds where he oversaw assets of $8B across 130 distinct funds. He has also served in the roles of CEO, President and Board Director for multinational companies like Prudential PLC, Honeywell, Colliers and Jones Lang LaSalle. Dylan was recognized as a Fortune 1000 CEO with P&L responsibility in excess of $3B and operations encompassing 15,000 employees in over 60 countries. In addition, Dylan has participated in 4 IPOs over the course of his career. Dylan is a leading advocate of space manufacturing and the utilization of in-space resources to further space exploration and settlement. In 2017, he became the first private citizen to manufacture an item in space when the gravity meter he co-designed and commissioned was 3D printed on the International Space Station. The historic item is now housed in the Museum of Science and Industry in Chicago.Dylan is an explorer of note. On December 11th, 2021 Dylan became just the 606th human to go to space as part of the crew of Blue Origin’s NewShepard Mission 19. Accordingly, Dylan earned his commercial astronaut wings with the FAA and his universal astronaut wings from the Association of Space Explorers.He is also one of only a handful of humans to have descended to the deepest part of the world’s oceans, Challenger Deep in the Mariana Trench as part of the Limiting Factor Expedition in July of 2022. In that mission, Dylan descended with pilot Victor Vescovo to a depth in excess of 10,800 meters (35,500 feet) into an area of the Mariana Trench that had never been visited by humans. Dylan is the youngest human to have been to the deepest part of the world’s oceans and crossed the Karman line into Space. Dylan has been a member of the Explorers Club since 2014.Dylan maintains an extensive philanthropic impact on the space industry. In 2017, Dylan founded the nonprofit and social movement, Space for Humanity, which seeks to democratize space exploration and develop solutions to global issues through the scope of human awareness to help solve the world’s most intractable problems. Space for Humanity has successfully sent two citizen astronauts to space via Blue Origin including both the first Mexican-born woman (Katya Echazareta), and first African-born woman (Sara Sabry). Building upon his passion and support for the space industry, Dylan serves as a strategic advisor for both the Archmission and the Human Spaceflight Program and is a co-founding patron of the Commercial Spaceflight Federation, which promotes the growth of commercial space activity. Additionally, he is also a leading benefactor to the Brooke Owens Fellowship, Patti Grace Smith Fellowship and Mission: Astro Access.Dylan is the founder and Chairman of Multiverse Media, an integrated global media company focused on science and technology, with an emphasis on space. Multiverse is the parent company of the popular space philosophy website 2211.world as well as the Ad Astra Dinners, a Jeffersonian-style dinner series featuring some of the world’s leading influencers discussing the future of humanity in space. Another subsidiary of Multiverse Media, Multiverse Publishing, publishes books by leading authors including Frank White, Isaac Asimov and Gerard K. O’Neill. Multiverse is also the executive producer of the documentary film, The High Frontier and the forthcoming film, Fortitude. For his influence as a global leader and his commitment to creating a positive impact on the world, Dylan has been honored with numerous personal and professional accolades in recent years. The World Economic Forum recognized Dylan as a Young Global Leader in 2011 and a full member of the World Economic Forum in 2014. That same year he was named a Henry Crown Fellow of the Aspen Institute. In 2020, Dylan was recognized by the Commercial Spaceflight Federation with their top honor for business and finance, following in the footsteps of 2019’s inaugural winner, the late Paul Allen and subsequent winners Jeff Bezos and Elon Musk.Dylan Taylor earned an MBA in Finance and Strategy from the Booth School of Business at University of Chicago and holds a BS in Engineering from the honors college at the University of Arizona, where he graduated Tau Beta Pi and in 2018 was named Alumnus of the year. He is also a graduate of the Global Leadership and Public Policy for the 21st Century program at Harvard University.Dylan and his family reside in Denver, Colorado where he is active locally with Colorado Concern and the Colorado Spaceport. In his spare time, Dylan enjoys hiking, competing in triathlons and spending time outdoors. As a weekend warrior athlete, Dylan has more than 25 top ten finishes and 25 age group wins to his credit, and he regularly interviews world class athletes whom have shown extraordinary resilience as the host of the Legendary Podcast. He is married to legal expert, consultant and author Gabrielle V. Taylor with whom he has two teenage daughters.
Show more...Investment focus
- Aerospace, Space Travel, Satellite Communication
- Seed, Series A, Funding Round
- United States, Canada, Finland
Portfolio highlights
- Xplore — Xplore is flying commercial missions in Earth orbits with their XCRAFT™, and they invite you to join us. They take civilian, commercial and national security payloads to their desired orbit around Earth for their science or reconnaissance missions.
- Space Forge — Space Forge make super materials in space that cannot be made on earth.
- Spaced Ventures — Spaced Ventures is a public investment platform for the space industry. Their platform gives direct access to investment deals and lets them back the hottest space startups. It was founded in 2020 and is based in Florida.
Joe Beverly
Show more...Investment focus
- Marketing, Advertising, Life Science
- Pre-Seed, Series A
- United States
Portfolio highlights
- MooveGuru — MooveGuru helps real estate agents and brokerages maintain relationships with clients from this move to the next.
- Lena Biosciences — Lena Biosciences 3D cell culture products and services
Jim Greer is the Chief Executive Officer at Bash. He was the co-founder and Chief Executive Officer of Kongregate. Before founding Kongregate in June 2006, Jim was Technical Director for Pogo at Electronic Arts. He has worked in the game industry since 1991.
Show more...Investment focus
- Health Care, Life Science, Biotechnology
- Seed
- United States
Portfolio highlights
- Vium — Vium's Digital Vivarium offers high precision animal models with low-touch non-invasive monitoring for improved study accuracy and reproducibility.
Nimi Katragadda is an investor at BoxGroup, which is a seed stage venture fund that invests in entrepreneurs building companies with visions to create the next generation of category defining businesses. Prior to joining BoxGroup, Katragadda worked at Google and J.P. Morgan. She holds a MBA from Harvard Business School and a BA in Economics fromHarvard.
Show more...Investment focus
- Biotechnology, Medical, Health Care
- Seed, Pre-Seed, Series B
- United States
Portfolio highlights
- Vial — Vial is a global, full-service CRO delivering faster, more efficient clinical trials for biotech, powered by experienced ClinOps and technology leaders.
- Ansa — The closed loop platform built for your customers.
- Prime Discoveries — Prime Discoveries develops rapid, novel diagnostics for COVID (Omicron) that can help laboratories scale and test millions of samples.
Leonardo DiCaprio is an American actor and film producer. He has been nominated for three Academy Awards and nine Golden Globe Awards. He won the Golden Globe Award for Best Actor for his performance in The Aviator (2004), and has been nominated by the Screen Actors Guild, Satellite Awards, and the British Academy of Film and Television Arts. Acommitted environmentalist, DiCaprio has received praise from environmental groups for his activism. At the 2007 Oscar ceremony, DiCaprio and former Vice President Al Gore announced that the Academy Awards had incorporated environmentally intelligent practices throughout the planning and production processes, and on July 7, 2007, DiCaprio presented at the American leg of Live Earth.
Show more...Investment focus
- Food and Beverage, Food Processing, Software
- Series A, Funding Round, Series B
- United States, Israel, United Kingdom
Portfolio highlights
- Polestar — Wir stellen Performance-Elektroautos her. Unser Ziel: eine bessere Zukunft durch Innovationen.
- LOCI — LOCI is an online shop that offers products for men and women. It was founded in the year of 2019, and the headquarter is in London, United Kingdom.
- NUVIEW — Explore NUVIEW's LiDAR satellite technology, revolutionizing Earth observation with annual global mapping, unrivaled coverage, and cutting-edge data.
Lu, the founder of Biosensors International Group Ltd, was its chairman and CEO from its inception to 2008. He retained his leadership position as chairman of the Group since January 2008. Today BIG is one of the leading medical device companies with a market cap in excess of $1.6B.
Show more...Investment focus
- Medical, Health Care, Artificial Intelligence
- Seed, Series A
- United States
Portfolio highlights
- Bot MD — Bot MD Care is an A.I. clinical chat assistant. Our A.I. integrates hospital information to provide instant answers to doctor queries and helps automates patient monitoring.
- BioTrillion — We so often think of Healthcare as an industry, that we tend to forget about Healthcare as a purpose. Globally and annually, trillions of dollars are ineffectively spent on healthcare and trillions of life data points are ineffectively connected to insights about our health. There is a better way.BioTrillion is a little startup with boldambitions to more efficatiously and scalably advance Healthcare – via Digital Biomarkers.Every human generates massive amounts of life data that will unlock novel health insights & applications. BioTrillion is developing a mobile health technology platform called BioEngine4D™ – for digitally detecting dangeous drugs, digitally detecting developing diseases, and data driven drug development – by measuring data from life, analyzing it through computational advancements in machine learning and artificial intelligence, and applying it back for life.BioTrillion, Inc. is headquartered in San Francisco, CA and is reimagining Life Sciences through the fundamental principles of many sciences.Our mission is to enable consumer smart devices to empower ordinary consumers with extraordinary health insights. Advances in technology have amplified our individual capabilities in many ways, and healthcare should be no exception.Website: www.biotrillion.com Contact: contact@biotrillion.com Jobs: https://www.biotrillion.com/opportunities Application: https://biotrillion.typeform.com/to/wSvoKI
CEO and Co-founder at Verge Genomics; Angel Investor in Tech-Enabled Bio
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Seed, Series A, Pre-Seed
- United States, United Kingdom
Portfolio highlights
- Encellin — Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics. It has dedicated experts focused on the investigation and advancement of next-generation therapies. It aims to help patients with chronic diseases, starting with Type 1 diabetes. It was founded in 2016 and is headquartered in San Francisco, California.
- Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
- Arpeggio Bio — Arpeggio Biosciences leverages state of the art sequencing approaches coupled with powerful machine learning to uncover novel insights into a compound's biological mechanism of action.The company is diverse set of molecular biologists, computer scientists, and biotechnology enthusiasts passionate about understanding where, why, and howtherapeutics work.
Julia is an advisor to start ups and an active technology angel investor, with angel investments in Gusto, Lever, Baobab Studios, Brit Media, BetterUp, SafeGraph, CodeFights, AltSchool, MissionU, Owlet, Philz Coffee, Tynker, Happiest Baby, Kite, MileIQ (acq by MSFT), Locu (acq by GoDaddy), Beme (acq by CNN), Alt12 (acq by Honest Co), Worklife (acqby Cisco) & Wheelz (acq by Turo), and later stage investments in Uber, Alibaba (IPO’d), FlipKart, Postmates, DocuSign, Survey Monkey, Blue Bottle Coffee, Stripe and Spotify.Julia began her career as a corporate attorney at Wilson Sonsini Goodrich Rosati. In 2006, Julia joined Facebook as the second attorney in the legal department and led the commercial transactions team from June 2006 until April 2011. She negotiated numerous deals strategic to Facebook's growth and development, including with Microsoft, Spotify, ABC/Disney, CNN and YouTube. Julia led a team of 9 attorneys, oversaw Facebook's legal work related to its international expansion and operations, and worked on matters related to product and IP law. In her five years at Facebook, Julia was instrumental in scaling the legal team from two people to 40, setting up departmental procedures and infrastructure and hiring and managing outside counsel. Julia received her JD from Harvard Law School in 1997, graduating cum laude, and her BA from UC Berkeley, graduating magna cum laude and phi beta kappa with a degree in Political Science. She is a member of the State Bar of California.In her free time, Julia volunteers at her kids' schools and with other community organizations. She has chaired the annual auctions at Bing Nursery School and Nueva School and is on the National Council of World Wildlife Fund. Previously, she sat on the boards of the Oshman Family JCC, Hebrew Free Loan Association and Hands on Bay Area. She biked from SF to LA with the California AIDS Ride and ran the Honolulu Marathon with Team in Training.
Show more...Investment focus
- Software, Machine Learning, Artificial Intelligence
- Seed, Series A, Pre-Seed
- United States, Canada, Colombia
Portfolio highlights
- Celo — Celo is global payments infrastructure that makes financial tools accessible to anyone with a mobile phone
- Dondo — Get what you want giving what you have
- UploadVR — VR & AR news, reviews, guides, and industry analysis.
Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Seed, Series A, Series B
- United Kingdom, United States, Canada
Portfolio highlights
- Nuclera — Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis. Nuclera has since grown to fifty-seven employees across two continents as the Company delivers on its founders’ vision to make biology accessible to everyone through desktop bioprinting. With desktop bioprinting, researchers and scientists will be empowered totake control of biology through streamlined access to a next-day supply of proteins and genes.
- SolasCure — Our proprietary technology leverages biomimicry and evidence-based medicine to treat patients with chronic wounds.
- PharmEnable — Designing the next generation of small molecule drugs. Replicating the specificity of biologics in the scalable form of a small molecule.
Evan Cheng Co-founder & CEO at Mysten Labs. He attended Syracuse University.
Show more...Investment focus
- Software, Artificial Intelligence, Biotechnology
- Seed, Pre-Seed, Series A
- United States, United Kingdom, Australia
Portfolio highlights
- PARSIQ — Comprehensive tools for analyzing, detecting, and preventing cryptocurrency fraud.
- Verida — The Verida Wallet is a mobile application that allows you to manage your decentralized identity and personal data. It provides a user-friendly interface for interacting with applications built on the Verida network.
- Kernal Biologics — Kernal biologics is an onco-selective mRNA therapeutics company located in Cambridge, MA
Nitesh Banta is the Co-Founder & CEO at B12.
Show more...Investment focus
- Software, Information Technology, FinTech
- Seed, Series A, Pre-Seed
- United States, Canada, United Kingdom
Portfolio highlights
- Yumari — Wholesale Buying from Latin America Made Easy
- Beam — Take control of your finances, all in one place. Say goodbye to paperwork, spreadsheets, and hours of manual data entry.
- K2 Space — By breaking the historic correlation between mass and cost, the K2 Space satellite bus offers the capabilities of large satellites at the price point of small satellites. A multi-orbit spacecraft for use across commercial, scientific and defense missions.
Paul B. Manning has served as the chairman of our board of directors since December 2017 and as a member of our board of directors since December 2015. Mr. Manning is the Chairman and Chief Executive Officer of PBM Capital Group, LLC, a private equity investment firm in the business of investing in healthcare and life-science related companies,which he founded in 2010. Prior to that, Mr. Manning founded PBM Products in 1997, a producer of infant formula and baby food, which was sold to Perrigo Corporation in 2010. Mr. Manning is a director of Dova Pharmaceuticals, Inc., a publicly traded pharmaceutical company, as well as various private companies. Mr. Manning was previously on the board of directors of Perrigo Corporation, Concordia Healthcare Corp. and AveXis, Inc. Mr. Manning received a B.S. in microbiology from the University of Massachusetts.
Show more...Investment focus
- Biotechnology, Therapeutics, Medical
- Series A, Series B, Seed
- United States
Portfolio highlights
- Kriya Therapeutics — Kriya is a next-generation gene therapy company focused on designing and developing transformative new treatments for highly prevalent and severe chronic diseases. We target conditions where the underlying biology is well-understood, rationally designing one-time gene therapies to durably express therapeutic proteins within the appropriate humantissues. Our team has deep expertise in the field and includes former senior leadership from pioneering gene therapy companies and academic institutions. We use algorithmic tools, scalable infrastructure, and proprietary technology to optimize the efficacy and durability of our gene therapies – with a goal of transforming the treatment paradigm for some of the most serious and widespread diseases.
- Xalud Therapeutics — Xalud Therapeutics is a clinical-stage biotechnology company developing a non-viral gene therapy platform to treat pathologic inflammation through immune modulation.
- Liquidia Technologies — Liquidia Technologies is a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using our proprietary PRINT technology to transform the lives of patients. PRINT technology is a particle engineering platform that enables the precise production of uniform drug particles designed toimprove the safety, efficacy, and performance of a wide range of therapies. Currently, Liquidia is developing two product candidates from its own pipeline: LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain. In addition to developing our own product candidates, Liquidia collaborates with leading pharmaceutical companies to apply our PRINT technology across a wide range of therapeutic areas, molecule types, and routes of administration.
Avichal is Managing Partner at Electric Capital. He is a serial entrepreneur and technology executive. Avichal sold two companies and was most recently Director of Product at Facebook, which acquired his company Spool in 2012. He previously worked at Google on search ranking and ads ranking, is part-time at YCombinator, and an active angelinvestor.Avichal's firm, Electric Capital, focuses on cryptocurrencies that are rooted in technological utility. Electric performs deep technological diligence, such as compiling code, profiling nodes, and analyzing blockchains with in-house software. The founders of Electric have started and sold five companies, have been investing in cryptocurrencies since 2013, and are investors in Anchor, Bitwise, Chia, Coda, dYdX, Dfinity, Oasis, Thunder and many other crypto projects.
Show more...Investment focus
- Software, Blockchain, Financial Services
- Seed, Series A, Pre-Seed
- United States, Canada, Mexico
Portfolio highlights
- Pulley — Pulley has helped thousands of companies manage their cap table and equity. Onboard with us today.
- Soul Wallet — Soul Wallet is a smart contract wallet.
- Magrathea — Magrathea Metals is a mining company that unlocks centuries of growth in human civilization by reducing the socioenvironmental impacts.
Scott Garber is the Managing Partner of Early Light Ventures. He attended The George Washington University School of Business.
Show more...Investment focus
- Software, Information Technology, Cyber Security
- Seed, Pre-Seed, Series A
- United States
Portfolio highlights
- Ethix360 — ETHIX360 provides Compliance as a Service (CaaS); a simple, affordable answer to employee ethics communication and human resources case management.
- Ash & Erie — Men's clothes designed from scratch for shorter men 5'8" and under. Find men's casual and formal clothing from button-downs, t-shirts, sweaters, denim jeans, chinos, and more. FREE Shipping, Exchanges, and Returns.
- Outlogic — Outlogic is a provider of location data for the retail, real estate, and financial markets. Outlogic has exemplified high standards and best practices for the collection and use of location data while still allowing companies to develop disruptive tools built on a foundation of quality data.
Edward Kliphuis - Partner @ Sofinnova Partners
Show more...Investment focus
- Biotechnology, Therapeutics, Health Care
- Series A, Series C, Seed
- United States, France, Israel
Portfolio highlights
- BioCorteX — BioCorteX is a techbio that applies deep technology to deliver effective therapeutics and de-risk the pharma pipeline by leveraging the synergy between drugs and bacteria
- Kiro — Kiro is an IT company that offers artificial intelligence, ergonomic design, and software development solutions for medical biology.
- Padlock Therapeutics — Padlock is developing medicines targeting protein-arginine deiminases (PADs), enzymes with an important role in the generation of autoantigens, inflammation,and immune complexes in autoimmune diseases. Padlock intends to explore the full biological and therapeutic footprint of protein deimination by PADs.Padlock was founded by scientists at TheScripps Research Institute and members of the Atlas Venture Life Sciences Team. Padlock's investors include Atlas Venture, Johnson & Johnson, and MS Ventures.Padlock is a seed company operating out of the Atlas Venture office in Cambridge MA.
Norman Sorensen who is a Class II director, joined the Board of Directors in March 2015. He is a member of the Company’s Finance, Risk Management and Audit Committee. Mr. Sorensen formerly served as chairman of the International Insurance Society, Inc., a professional organization for the insurance industry, from January 2010 until June 2013. Mr.Sorensen has served as a director of the International Insurance Society, Inc. since January 2005. Previously, from November 2011 until December 2012, he was chairman of the International Advisory Council of Principal Financial Group, Inc., a global financial investment management company. He was chairman of Principal International, Inc., serving from June 2011 to October 2012, and president and CEO of International Asset Management and Accumulation of Principal International, Inc., serving from January 2001 to June 2011. Mr. Sorensen has served as a director of Encore Capital Group, Inc., a consumer banking company, since November 2011. Mr. Sorensen also served as a director of Sara Lee Corporation, an American consumer-goods company, from January 2007 to November 2011. He has served as executive vice president of both Principal Financial Group Inc. and Principal Life Insurance Company, a life insurance company, since January 2007, and held a number of other senior management positions since 1998. Mr. Sorensen also served as chairman of the U.S. Coalition of Service Industries, a leading forum for the services sector, from January 2003 to March 2005. Mr. Sorensen served as a senior executive of American International Group, Inc., an insurance services company, from September 1989 to December 1998. He also formerly served as chairman and director of DE Master Blenders, from December 2011 until September 2013.
Show more...Investment focus
- SaaS, FinTech, Analytics
- Seed
- United States
Portfolio highlights
- Solidus Labs — The first automated, comprehensive and testable market surveillance and risk monitoring hub tailored for digital assets
- Thrive Bioscience — Thrive Bioscience is commercializing a family of instruments and software that provide imaging, analytics, and automation to significantly improve cell culture and the analysis of live cells. Thrive’s instruments empower biologists to deliver consistent, reproducible results by leveraging microscopy, robotics, fluidics, and other fields, to captureimages and data and provide analysis, reports, guidance, documentation, and a database on the cells and on cell culture processes.
Ali Shaaban has been a pioneer in the digital advertising and communications industry for more than 18 years, founding the award-winning full-fledged creative digital agency Icon Creations back in 2003 when the industry was at its infancy stage. Since then, Ali Shaaban has built strong long-term relationships and a strategic network with most ofthe leading automotive brands in Egypt and the Middle East, where he established a solid track record of delivering top-notch digital products & services that stood the test of time. Driven by passion for excellence and an always-on personalized approach to satisfying his partners, Ali Shaaban is the quintessential digital partner to have on your side in the automotive industry today.His automotive portfolio includes Alfa Romeo, Bentley, BMW, Castrol, Citroën, Ferrari, Fiat, Ford, Hyundai, JAC, Jaguar, Jeep, KIA, Land Rover, Maserati, Mazda, MINI, Mitsubishi, Nissan, Peugeot, Pirelli, Renault, Seat, Subaru, Toyota, Volkswagen and more. Aside from being a digital pioneer, Ali Shaaban is also an angel investor and serial supporter of emerging innovative startups and fresh business ideas, venturing into several sectors to contribute in making a sustainable impact on the local and regional economies. His latest investments have tapped into the Fintech sector with rising companies such as Paynas (https://Paynas.com), Oxygen (https://oxygen.us/), Dfin Holding (https://www.dfinholding.com/) , and Kiwe wallet (https://kiweapp.com/) as well as the Media and AI sector with Speakol (https://speakol.com/) , NU Digital Awards (https://nudigitalawards.com/) and Nanotronics (https://nanotronics.co/ ).Ali Shaaban believes in always taking the next step forward in his extensive career, and using his core values and commanding personality as motivation, he has paved an impressive path over the years that will certainly lead towards an even more diverse and fruitful future.
Show more...Investment focus
- Financial Services, FinTech, Banking
- Series A, Seed, Pre-Seed
- Egypt, United States, Kenya
Portfolio highlights
- ImaliPay — ImaliPay is a financial health platform offering financial products to freelancers and blue collar gig workers in partnership with gig platforms.
- QuadriBot — QuadriBot is an engineering company specializing in the design and development of electronics and automation technology, real-time systems and the development of IT and electronic solutions around smart transportation issues. We focus on robotics and autonomous vehicles as well as any mobile platfo.
- Nanotronics Imaging — At Nanotronics we provide customized solutions for automated optical inspection, process control, and security. Learn more about what we can do for you.
Close your round
Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.
Find investors — It's Free!Join 21,000+ founders from: